Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia

Heart. 2009 Apr;95(7):584-7; discussion 587-91. doi: 10.1136/hrt.2008.162909. Epub 2009 Jan 23.

Authors

R Minhas¹, S E Humphries, N Qureshi, H A W Neil; NICE Guideline Development Group

Collaborators

NICE Guideline Development Group:
Leo Nherera, Elisabeth Shaw, Meeta Kathoria, Gill Ritchie, Vanessa Nunes, Dawn Davies, Philip Lee, Ian McDowell, Andrew Neil, Nadeem Qureshi, Philip Rowlands, Mary Seed, Helen Stracey, Margaret Thorogood, Melanie Watson

Affiliation

¹ RAND Health, RAND Corporation, Santa Monica, Los Angeles, CA 90407, USA. rminhas@rand.org

PMID: 19168470
DOI: 10.1136/hrt.2008.162909

No abstract available

Publication types

Practice Guideline
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Aged
Cholesterol / blood
Cholesterol / genetics
Cost-Benefit Analysis
Family Health
Female
Humans
Hydroxymethylglutaryl CoA Reductases / therapeutic use
Hyperlipoproteinemia Type II / diagnosis*
Hyperlipoproteinemia Type II / drug therapy
Hyperlipoproteinemia Type II / genetics
Male
Middle Aged
Sequence Analysis, DNA

Substances

Cholesterol
Hydroxymethylglutaryl CoA Reductases